AzTrials
AzTrials

StrokeNCT03632070

Factors Related to Functional Recovery Using Brain Imaging of Stroke Patients

An observational study of Stroke, run by Samsung Medical Center at 1 site in South Korea.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

In this study, brain imaging predictive factors related to motor recovery will be investigated. Lastly, the prediction model will be established. Read more about this study

Who is it for?
Ages 19 years and older
Conditions the study is for
Stroke
What is being tested?
Data acquisition of functional abilities
How many people
73 participants
Where
1 siteSouth Korea
Study dates
9 Aug 2018to 24 Aug 2020
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 19 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients with ischemic stroke who were admitted to Samsung Medical Center and transferred to the Department of Physical and Rehabilitation Medicine

Who may be able to join

  • Adults more than 19 years
  • First-ever unilateral stroke
  • Ischemic subacute stroke patients

Who cannot join

  • Major active neurological disease or psychiatric disease
  • Metallic implants in their brain
  • Hemorrhagic stroke
  • Bilateral lesions
  • Recurrent stroke

Trial locations and contacts

1 site in 1 country.

South Korea1 site
  • Samsung Medical Center

    Seoul, 06351

Other trials in South Korea

About this study

Official title: A Study on Factors Related to Functional Recovery Using Brain Imaging of Stroke Patients

In this study, brain imaging predictive factors related to motor recovery will be investigated. Lastly, the prediction model will be established.

Conditions
Stroke
Being tested
Data acquisition of functional abilities
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Data acquisition of functional abilitiesBehavioural

    MRI data, motor evoked potentials, and behavior data acquisition

Study groups in NCT03632070
Study groupRoleWhat they receive
StrokePatients with ischemic or hemorrhagic stroke who were admitted to Samsung Medical Center and transferred to the Department of Physical and Rehabilitation Medicine
Receives: Behavioral: Data acquisition of functional abilities

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Fugl-Meyer Assessment score at 3 months after stroke onset

    Measurement of motor function of upper and lower extremities

    Measured: 3 months after stroke onset]

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Aug 2018
  2. Study start9 Aug 2018
  3. Primary completion24 Aug 2020
  4. Study completion24 Aug 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Retrospective
Enrolment
73 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03632070
Sponsor's protocol ID
2018-07-168
Status last verified
Aug 2020
First submitted
13 Aug 2018
Last updated
4 Sep 2020
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Stroke, run by Samsung Medical Center at 1 site in South Korea.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 4 Sep 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Fugl-Meyer Assessment score at 3 months after stroke onset (time frame: 3 months after stroke onset]). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Sep 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in